John C. Drach

Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole <scp>l</scp> -Riboside with a Unique Mode of Action

Karen K. Biron, Richard J. Harvey, Stanley C. Chamberlain et al. · Antimicrobial Agents and Chemotherapy · 2002 · 361 citations · Full text

Viral Replication, Unique Mode, Molecular Biology +18

Design, Synthesis, and Antiviral Evaluations of 1-(Substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as Nonnucleoside Analogues of 2,5,6-Trichloro-1-(β-<scp>d</scp>-ribofuranosyl)benzimidazole

Anthony R. Porcari, Rodrigo V. Devivar, Louis S. Kucera et al. · Journal of Medicinal Chemistry · 1998 · 272 citations · Full text

Design, Synthesis, and Antiviral Activity of α-Nucleosides:  <scp>d</scp>- and <scp>l</scp>-Isomers of Lyxofuranosyl- and (5-Deoxylyxofuranosyl)benzimidazoles

Michael T. Migawa, Jean‐Luc Girardet, John Walker et al. · Journal of Medicinal Chemistry · 1998 · 211 citations

Inhibition of Human Cytomegalovirus DNA Maturation by a Benzimidazole Ribonucleoside Is Mediated through the UL89 Gene Product

Mark Underwood, Richard J. Harvey, Sylvia C. Stanat et al. · Journal of Virology · 1998 · 192 citations · Full text

Bdcrb-resistant Virus, Viral Replication, Molecular Virology +15

Design, Synthesis, and Antiviral Activity of Certain 2,5,6-Trihalo-1-(.beta.-D-ribofuranosyl)benzimidazoles

Leroy B. Townsend, Rodrigo V. Devivar, Steven R. Turk et al. · Journal of Medicinal Chemistry · 1995 · 187 citations